Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

The Pharmaceutical Journal

Editorial

National targets to reduce antibiotic prescribing should be reduced in order to fight the increase of antimicrobial resistance

Putting the brakes on antibiotic useSubscription

The UK government should support calls from across the health service for national targets to reduce antibiotic prescribing, before resistance robs us of vital treatments.

Feature

New drugs are under development to reduce the use of antibiotics in animals and help slow the rise of antimicrobial resistance in humans

Strategies to reduce the use of antibiotics in animalsSubscription

By

New drugs that could eventually replace or reduce the use of antibiotics in animals are in development to help slow the rise of antibiotic resistance.

Learning article

Growing antimicrobial resistance is growing and results in 25,000 deaths in Europe each year. In the image, enterobacteriaceae (CRE) bacterium in an antibiotic susceptibility test proved to be resistant to all of the antibiotics tested

Improving antimicrobial stewardshipVideoSubscription

By

Improve your practice and slow the increasing levels of antimicrobial resistance that already cost around 25,000 deaths across Europe each year.

CPD article

Chlamydia (pictured) is one of a series of sexually transmitted infections (STIs) that have increased considerably in the last ten years

Treating bacterial sexually transmitted infectionsSubscription

By , ,

With azithromycin made available over the counter for chlamydia treatment, this CPD article reviews how to identify and treat the most prevalent sexually transmitted infections.

Careers

Derek Woodcock is a Qualified Person for Pharmacovigilance and consultant for a variety of pharmaceutical companies

Ensuring medicines safety and managing risk as a Qualified Person for PharmacovigilanceSubscription

By

Derek Woodcock is a Qualified Person for Pharmacovigilance and works as a consultant for a variety of pharmaceutical companies. Here, he explains why pharmacovigilance does not have to be seen as the department of “bad news”.

News

Researchers find way to target RAS protein (pictured), the most frequently mutated oncogene in a third of human cancers

Breakthrough in targeting KRAS gene mutation implicated in many cancersSubscription

Researchers have identified an agent that interferes with the cell signalling protein KRAS and which produces a dose-dependent reduction in tumour growth in a mouse model.

The General Pharmaceutical Council (GPhC) acts fairly in fitness-to-practise cases, says recent review

Review of fitness-to-practise cases suggests pharmacy regulator acts fairlySubscription

Pharmacists are likely to be dealt with fairly if they find themselves up before the professional regulator’s fitness-to-practise committee, according to published research.

The Pharmaceutical Journal

15 November 2014, Vol 293, No 7836

Cover Story:

New drugs that could eventually replace or reduce the use of antibiotics in animals are in development to help slow the rise of antibiotic resistance.

Read more…

The Pharmaceutical Journal

View previous issue

YOUR RPS

Helen Gordon, chief executive of the Royal Pharmaceutical Society

Teamwork will define the future NHSSubscription

By

Greater partnership between pharmacists and other health professions will be vital to delivering better care under the new five-year NHS plan, says Helen Gordon, chief executive of the Royal Pharmaceutical Society.

Notice-board

For latest notifications, opportunities and product updates, visit the notice-board page here.

Announcements

For official announcements from The Royal Pharmaceutical society please visit the announcements page here.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.